Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Minerva Cardioangiol ; 63(6): 533-46, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26334115

ABSTRACT

Therapy with dual antiplatelet agents, defined as the combination of a platelet P2Y12 inhibitor and aspirin, is required to prevent thrombotic complications, after percutaneous coronary intervention (PCI) with stent implantation. Usually current guidelines recommend administration of dual antiplatelet therapy (DAPT) following percutaneous revascularization with drug-eluting stent (DES) for a period of at least 12 months or for 6 to 12 months in patients not at high risk. Nevertheless, the treatment of stable/unstable coronary artery disease with DES implantation increasing largely, the optimal duration of DAPT is still unclear. The duration of DAPT after coronary stenting has been evaluated in recent randomized studies with conflicting results. The administration of long period of DAPT is a strategy to reduce thrombosis events but largely increase the hemorrhagic ones. Otherwise, shorter DAPT period is protective about bleeds with consequently increased ischemic events. In addition, as new DES carry a lower risk of stent thrombosis (ST) compared with the first-generation DES and possibly even bare-metal stents, a shift toward better protection from ST may have an effect on the duration and the intensity of DAPT. Whether the duration of DAPT should be shorter or longer than the currently recommended 6 to 12 months is analyzed in this review, drawing on results from the most recent studies and meta-analysis.


Subject(s)
Percutaneous Coronary Intervention/methods , Platelet Aggregation Inhibitors/administration & dosage , Thrombosis/prevention & control , Aspirin/administration & dosage , Aspirin/adverse effects , Aspirin/therapeutic use , Coronary Artery Disease/therapy , Drug Therapy, Combination , Drug-Eluting Stents/adverse effects , Hemorrhage/chemically induced , Humans , Platelet Aggregation Inhibitors/adverse effects , Platelet Aggregation Inhibitors/therapeutic use , Purinergic P2Y Receptor Antagonists/administration & dosage , Purinergic P2Y Receptor Antagonists/adverse effects , Purinergic P2Y Receptor Antagonists/therapeutic use , Randomized Controlled Trials as Topic
2.
Radiat Prot Dosimetry ; 165(1-4): 386-91, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25821212

ABSTRACT

The aim of this study was to compare the performance of three digital X-ray systems [one flat-panel (DR) and two computed radiography (CR)] for chest radiography in terms of the entrance surface air kerma (ESAK) delivered to a polymethyl methacrylate phantom of 20 cm (equivalent to an adult patient) and image quality through of numerical evaluations using a test object (TO). The tube charge applied was ranged from 0.6 to 32 mAs, to a fixed tension of 125 kVp. The DR system presented the highest mean values of ESAK (615.9 µGy) along with the highest signal-to-noise ratio values, whereas CR systems showed a better high-contrast spatial resolution. Differences were statistically significant in both cases regarding the tube charge used. Thus, this parameter should be mainly considered to optimise the radiological protection through exposure settings selected. This survey represents the first effort to achieve optimisation in digital radiology for Chile.


Subject(s)
Radiographic Image Enhancement/instrumentation , Radiographic Image Enhancement/methods , Radiography, Thoracic/instrumentation , Radiography, Thoracic/methods , Adult , Chile , Computer Systems , Humans , Phantoms, Imaging , Polymethyl Methacrylate , Quality Assurance, Health Care , Radiation Protection/standards , Signal-To-Noise Ratio , Software , X-Rays
3.
Knee ; 22(1): 30-5, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25480381

ABSTRACT

BACKGROUND: Different single-stage surgical approaches are currently under evaluation to repair cartilage focal lesions. To date, only little is known on even short-term clinical follow-up and almost no knowledge exists on histological results of such treatments. The present paper aims to analyze the clinical and histological results of the collagen-covered microfracture and bone marrow concentrate (C-CMBMC) technique in the treatment of focal condylar lesions of knee articular cartilage. METHODS: Nine patients with focal lesions of the condylar articular cartilage were consecutively treated with arthroscopic microfractures (MFX) covered with a collagen membrane immersed in autologous bone marrow concentrate (BMC) from the iliac crest. Patients were retrospectively assessed using several standardized outcome assessment tools and MRI scans. Four patients consented to undergo second look arthroscopy and biopsy harvest. RESULTS: Every patient was arthroscopically treated for a focal condylar lesion (mean area 2.5 SD(0.4) cm(2)). All the patients (mean age 43 SD(9) years) but one experienced a significant clinical improvement from the pre-operative condition to the latest follow-up (mean 29 SD(11) months). Cartilage macroscopic assessment at 12 months revealed that all the repairs appeared almost normal. Histological analysis showed a hyaline-like cartilage repair in one lesion, a fibrocartilaginous repair in two lesions and a mixture of both in one lesion. CONCLUSIONS: The first clinical experience with single-stage C-CMBMC for focal cartilage defects in the knee suggests that it is safe, it improves the short-term knee function and that it has the potential to recreate hyaline-like cartilage.


Subject(s)
Absorbable Implants , Arthroplasty, Subchondral/methods , Bone Marrow Transplantation , Cartilage, Articular/surgery , Knee Injuries/surgery , Tissue Engineering , Tissue Scaffolds , Adult , Cartilage, Articular/injuries , Collagen , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Pilot Projects , Retrospective Studies
4.
Minerva Cardioangiol ; 62(1): 19-27, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24500214

ABSTRACT

Since the advent of coronary angioplasty the treatment of bifurcation lesions has always proved a complex issue resulting in lower angiographic success rates, increased risk of restenosis, higher rates of dissection, myocardial infarction, and acute vessel closure. The advent of coronary stenting reduced the risks, but in-stent restenosis was noted to be frequent at the ostium of the side branch; for this reasons two-stent techniques were developed to try to combat this phenomenon. Novel dedicated stents have recently been developed to provide easier access to the SB and to scaffold more effectively its ostium, matching the stent configuration more closely to the anatomy of the bifurcation. Most of bifurcation lesions that require treatment and which have a wide angle involving the left main coronary artery (LMCA). The impact of the angle and the asymmetry of bifurcation on flow dynamic are very important and may influence clinical outcome. More recently, percutaneous coronary intervention (PCI) to treat wide angle disease has increased in frequency, and is associated with improvements in interventional techniques and adjunctive drug therapy. Several studies have shown that stenting in LMCA, especially using drug-eluting stents (DES), is a safe and effective treatment strategy both at mid- and long-term follow-up. The AXXESS System is a self-expanding, conically-shaped stent from nitinol (nickel-titanium alloy) with strut thickness, specifically designed to conform to the anatomy at the level of the bifurcation carina. A special version of the AXXESS System has been designed for left main bifurcation lesions, allowing for larger diameters (up to 4.75 mm) and distinct bifurcation angles (flare-end diameters of 8, 10 and 12 mm). The AXXENT trial is the first study to evaluate the vascular response of the self-expanding biolimus-eluting AXXESS stent for the treatment of LMCA bifurcation lesions. It was designed to evaluate the safety and efficacy of the AXXESS biolimus-eluting stent for the treatment of LMCA bifurcation lesions, that showed good results in terms of stent thrombosis and TLR at 6 months follow-up. Technical modifications and stent innovations may further improve both the angiographic and clinical outcomes for patients with wide angle bifurcation disease treated by PCI. Moreover a long term follow-up is needful to demonstrate better safety and efficacy of these new dedicated bifurcation devices.


Subject(s)
Coronary Artery Disease/surgery , Drug-Eluting Stents , Stents , Angioplasty, Balloon, Coronary/adverse effects , Angioplasty, Balloon, Coronary/methods , Coronary Artery Disease/pathology , Coronary Restenosis/epidemiology , Drug-Eluting Stents/adverse effects , Humans , Percutaneous Coronary Intervention/methods , Stents/adverse effects
5.
Rom J Intern Med ; 51(2): 119-22, 2013.
Article in English | MEDLINE | ID: mdl-24294816

ABSTRACT

A 30-years-old man, subjected to an electrocardiogram for screening, showed signs of left ventricular hypertrophy and "giant" inverted T-waves in pre-cordial leads. So, a transthoracic echocardiogram and a Coronary angiography were performed that showed first, a normal ventricular function and second, normal coronary arteries. Luckily, we associated to the Coronary angiography a Ventriculography that revealed a marked hypertrophy particularly in the apex and a 90% complete tele-systolic obliteration of the left ventricle. To better address our diagnosis, we performed a cardiac magnetic resonance that confirmed the Apical Hypertrophic Cardiomyopathy (AHCM) involving concentrically the apex known as "spade-like configuration" and an apical akinesia with slow-flow. Since the patient was totally asymptomatic, he was discharged without any treatment. AHCM is a form of Hypertrophic Cardiomyopathy (HCM) with an hypertrophy of the left ventricular apex. This disease is often sporadic and among the forms of HCM it has a benign prognosis although in > 50% of patients AHCM is symptomatic with chest pain and palpitations. Our patient incredibly never had cardiac symptoms and was always in a good health state, so only thanks to the association of Ventriculography to the Coronary angiography we were able to reach this unusual diagnosis.


Subject(s)
Asymptomatic Diseases , Cardiomyopathy, Hypertrophic/diagnosis , Adult , Cardiomyopathy, Hypertrophic/pathology , Coronary Angiography , Humans , Male , Radionuclide Ventriculography
6.
Knee ; 20(6): 562-9, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23642661

ABSTRACT

BACKGROUND: Different single-stage surgical approaches are currently under evaluation to repair focal cartilage lesions. This study aims to analyze the clinical and histological results after treatment of focal condylar articular lesions of the knee with microfracture and subsequent covering with a resorbable polyglycolic acid/hyaluronan (PGA -HA) matrix augmented with autologous bone marrow concentrate (BMC). METHODS: Nine patients with focal lesions of the condylar articular cartilage were consecutively treated with arthroscopic PGA -HA-covered microfracture and bone marrow concentrate (PGA -HA-CMBMC). Patients were retrospectively assessed using standardized assessment tools and magnetic resonance imaging (MRI). Five patients consented to undergo second look arthroscopy and 2 consented biopsy harvest. RESULTS: All the patients but one showed improvement in clinical scoring from the pre-operative situation to the latest follow-up (average 22±2months). The mean IKDC subjective score, Lysholm score, VAS and the median Tegner score significantly increased from baseline to the latest follow-up. Cartilage macroscopic assessment at 12months revealed that one repair appeared normal, three almost normal and one appeared abnormal. Histological analysis proofed hyaline-like cartilage repair tissue formation in one case. MRI at 8 to 12months follow-up showed complete defect filling. CONCLUSIONS: The first clinical experience with single-stage treatment of focal cartilage defects of the knee with microfracture and covering with the PGA -HA matrix augmented with autologous BMC (PGA -HA-CMBMC) suggests that it is safe, it improves knee function and has the potential to regenerate hyaline-like cartilage. LEVEL OF EVIDENCE: IV, case series.


Subject(s)
Absorbable Implants , Arthroplasty, Subchondral/methods , Bone Marrow Transplantation , Cartilage, Articular/surgery , Tissue Engineering , Tissue Scaffolds , Adult , Biopsy, Needle , Cartilage, Articular/injuries , Cartilage, Articular/pathology , Female , Humans , Hyaluronic Acid , Immunohistochemistry , Knee Injuries/diagnosis , Knee Injuries/surgery , Magnetic Resonance Imaging/methods , Male , Middle Aged , Pilot Projects , Polyglycolic Acid , Risk Assessment , Sampling Studies , Transplantation, Autologous , Treatment Outcome
7.
Minerva Cardioangiol ; 61(1): 61-70, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23381381

ABSTRACT

Coronary bifurcation lesions are regarded as complex and their treatment is still the subject of substantial debate. Important elements to consider before approaching a bifurcation include angle and anatomy, in particular the take off angle (proximal angle, A) that is between the proximal MB and SB and the carina angle (distal angle, B) that is between distal main branch (MB) and side branch (SB) and also the extent and distribution of disease on the side branch and its size. Many techniques have been used to treat coronary bifurcation lesions such as provisional stenting or double stenting but no consensus technique has been accepted primarily due to variation of disease severity, angle and anatomy. Angle B is the unique statistically significant independent predictor factor influencing outcomes. Bifurcation angle and anatomy are important predictors of short and long-term outcomes after bifurcation treatment. Moreover we should evaluate it after wiring MB and SB so as after pre-dilatation because of side branch access and carina area angle anatomy variation and plaque shift. Should be investigated if the developing of new dedicated devices for bifurcation lesions could mix the advantages of one and two-stent techniques.


Subject(s)
Coronary Stenosis/surgery , Coronary Vessels/anatomy & histology , Stents , Humans , Treatment Outcome
8.
Int J Immunopathol Pharmacol ; 24(1 Suppl 2): 69-72, 2011.
Article in English | MEDLINE | ID: mdl-21669141

ABSTRACT

Chondral articular defects are a key concern in orthopaedic surgery. To overcome the disadvantages of autologous chondrocyte implantation (ACI) and to improve the outcomes of autologous matrix-induced chondrogenesis (AMIC), the latter technique is currently augmented with bone marrow concentrate injected under or seeded onto the scaffold. However, to date, only a little is known about histological outcomes of either the AMIC technique or AMIC associated with bone marrow concentrate. This study aimed to evaluate the quality of the repair tissue obtained from biopsies harvested during second-look arthroscopy after arthroscopic AMIC augmented with bone marrow concentrate. We analysed five second-look core biopsies harvested at 12 months follow-up. At the time of biopsy the surgeon reported the quality of the repair tissue using the standard ICRS Cartilage Repair Assessment (CRA). Every biopsy together with patient data was sent to our centre to undergo blind histological evaluation (ICRS II Visual Histological Assessment Scale) and data analysis. Five asymptomatic patients (mean age 43.4 years) had isolated lesions (mean size was 3.7 cm2) at the medial femoral condyle. All the implants appeared nearly normal (ICRS CRA) at arthroscopic evaluation and had a mean overall histological (ICRS II) of 59.8±14,5. Hyaline-like matrix was found in only one case, a mixture of hyaline/fibrocartilage was found in one case and fibrocartilage was found three cases. Our clinical and histological data suggest that this procedure achieved a nearly normal arthroscopic appearance and a satisfactory repair tissue, which was possibly still maturing at 12 months follow-up. Further studies are needed to understand the true potential of one-step procedures in the repair of focal chondral lesions in the knee.


Subject(s)
Bone Marrow Transplantation/methods , Cartilage, Articular/surgery , Collagen , Knee Injuries/surgery , Tissue Scaffolds , Adult , Arthroscopy , Biopsy , Biopsy, Needle , Cartilage/injuries , Cartilage/pathology , Cartilage, Articular/pathology , Female , Fibrocartilage/pathology , Follow-Up Studies , Humans , Hyaline Cartilage/pathology , Knee Injuries/pathology , Male , Middle Aged , Paraffin Embedding , Treatment Outcome , Young Adult
9.
G Ital Cardiol ; 29(5): 533-9, 1999 May.
Article in Italian | MEDLINE | ID: mdl-10367221

ABSTRACT

BACKGROUND: While syncope is generally considered a frequent finding in clinical practice, no clear epidemiological evidence is available about the relevance of such an event in the general population of Italy. METHODS: The OESIL Study was designed and undertaken in 15 hospitals of the Italian region of Latium in order to assess the percentage of emergency-room visits and admissions due to syncope, as well as to analyze the in-hospital diagnostic work-up performed for this condition. RESULTS: During a two-month observation period, 781 (372 males and 409 females, mean age 55.2 (22.8 years) consecutive patients came to the emergency rooms of the 15 hospitals included in the investigation due to a syncope spell (0.9% of emergency room visits); 450/781 patients (57.6%) were subsequently hospitalized (1.3% of all admissions): 48.0% of the admissions were admitted to a general medical ward, 29.3% to an observation ward, 13.3% to a cardiology section, 1.6% to a neurology section and 7.8% to other clinical sections (neurosurgery, general surgery). The mean duration of in-hospital stay was 6.9 (5.8 days; range 1-40 days). During the hospitalization period, 93.1% of patients underwent an ECG, 51.0% an EEG, 44.3% a CT scan of the central nervous system, 40.2% an echocardiogram and 19.5% a tilt-test. The syncope spell was considered to have a cardiovascular origin in 33.8% of the cases and a non-cardiovascular in 11.6% of the cases, while the origin was unknown in 54.4% of the cases. CONCLUSIONS: Collected data support the idea that syncope represents a frequent event in the general population and is responsible for a significant percentage of emergency-room visits and hospital admissions. However, the performance of conventional diagnostic work-ups is far from being satisfactory.


Subject(s)
Hospitalization , Syncope/therapy , Adult , Aged , Female , Hospitalization/statistics & numerical data , Humans , Incidence , Italy/epidemiology , Length of Stay/statistics & numerical data , Male , Middle Aged , Syncope/diagnosis , Syncope/epidemiology , Syncope/etiology
10.
Minerva Cardioangiol ; 40(4): 149-54, 1992 Apr.
Article in Italian | MEDLINE | ID: mdl-1528500

ABSTRACT

The aneurysm of the interatrial septum (ASA) is a rare congenital heart disease, easily recognizable by real time cross sectional two dimensional echocardiography. The ASA occurs as an isolated entity or may be associated with congenital heart disease. Usually ASA may cause serious complications such as embolic phenomena, atrial or ventricular tachyarrhythmia and eventually following a rupture or atrial shunt. The Authors a case of 44-year-old woman referred to hospital for a paroxysmal supraventricular tachyarrhythmia and found to have an ASA as isolated anomaly.


Subject(s)
Heart Aneurysm/congenital , Heart Septum , Adult , Echocardiography , Female , Heart Aneurysm/complications , Humans , Propranolol/therapeutic use , Tachycardia, Paroxysmal/drug therapy , Tachycardia, Paroxysmal/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...